1.
Vestn Oftalmol
; 104(2): 64, 1988.
Artigo
em Russo
| MEDLINE
| ID: mdl-3394210
2.
Vopr Onkol
; 32(1): 70-4, 1986.
Artigo
em Russo
| MEDLINE
| ID: mdl-3946089
RESUMO
High-sensitivity methods were employed to test blood serum for hepatitis B markers in 293 infant cancer patients. HBsAg was identified in 31.7 while anti-HBs--in 16.7% of cases. Hepatitis B markers most frequently occurred in patients suffering from lymphoproliferative diseases (60.1%). HBeAg was detected in 46.5% of patients with HBsAg. The results point to a high incidence of hepatitis B virus in cancer patients.